Cargando…

Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin

The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazra, Moumita, Dasgupta Mandal, Dalia, Mandal, Tamal, Bhuniya, Saikat, Ghosh, Mallika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834692/
https://www.ncbi.nlm.nih.gov/pubmed/27134546
http://dx.doi.org/10.1016/j.jsps.2015.01.007
_version_ 1782427528905883648
author Hazra, Moumita
Dasgupta Mandal, Dalia
Mandal, Tamal
Bhuniya, Saikat
Ghosh, Mallika
author_facet Hazra, Moumita
Dasgupta Mandal, Dalia
Mandal, Tamal
Bhuniya, Saikat
Ghosh, Mallika
author_sort Hazra, Moumita
collection PubMed
description The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the model drug quercetin through ionic cross linking method. In vitro drug release, swelling index, drug entrapment efficiency, Fourier Transforms Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Differential Scanning Calorimetric (DSC) studies were also done for physicochemical characterization of the formulations. Swelling index and drug release study were done at a pH of 1.2, 6.8 and 7.4 to evaluate the GI mimetic action which entails that the swelling and release of the all the Formulation1 (F1), Formulation2 (F2) and Formulation3 (F3) at pH 1.2 were minimal confirming the prevention of drug release in the acidic environment of stomach. Comparatively more sustained release was seen from the formulations F2 & F3 at pH 6.8 and pH 7.4 after 7 h of drug release profiling. Drug entrapment efficiency of the formulations shows in F1 (D:C:A = 2:5:30) was approximately 70% whereas the increase in chitosan concentration in F2 (D:C:A = 2:10:30) has shown an entrapment efficiency of 81%. But the comparative further increase of chitosan concentration in F3 (D:C:A = 2:15:30) has shown a entrapment of 80% which is not having any remarkable difference from F2. The FTIR analysis of drug, polymers and the formulations indicated the compatibility of the drug with the polymers. The smoothness of microspheres in F2 & F3 was confirmed by Scanning Electron Microscopy (SEM). However F1 microsphere has shown more irregular shape comparatively. The DSC studies indicated the absence of drug-polymer interaction in the microspheres. Our XRD studies have revealed that when pure drug exhibits crystalline structure with less dissolution profile, formulated microparticles can help us to obtain amorphous form of the same drug that is likely to have more dissolution property. The findings of the study suggest that the microsphere formulations were a promising carrier for quercetin delivery and can be considered as a favorable oral controlled release dosage form for hydrophobic drug quercetin.
format Online
Article
Text
id pubmed-4834692
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48346922016-04-29 Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin Hazra, Moumita Dasgupta Mandal, Dalia Mandal, Tamal Bhuniya, Saikat Ghosh, Mallika Saudi Pharm J Original Article The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the model drug quercetin through ionic cross linking method. In vitro drug release, swelling index, drug entrapment efficiency, Fourier Transforms Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Differential Scanning Calorimetric (DSC) studies were also done for physicochemical characterization of the formulations. Swelling index and drug release study were done at a pH of 1.2, 6.8 and 7.4 to evaluate the GI mimetic action which entails that the swelling and release of the all the Formulation1 (F1), Formulation2 (F2) and Formulation3 (F3) at pH 1.2 were minimal confirming the prevention of drug release in the acidic environment of stomach. Comparatively more sustained release was seen from the formulations F2 & F3 at pH 6.8 and pH 7.4 after 7 h of drug release profiling. Drug entrapment efficiency of the formulations shows in F1 (D:C:A = 2:5:30) was approximately 70% whereas the increase in chitosan concentration in F2 (D:C:A = 2:10:30) has shown an entrapment efficiency of 81%. But the comparative further increase of chitosan concentration in F3 (D:C:A = 2:15:30) has shown a entrapment of 80% which is not having any remarkable difference from F2. The FTIR analysis of drug, polymers and the formulations indicated the compatibility of the drug with the polymers. The smoothness of microspheres in F2 & F3 was confirmed by Scanning Electron Microscopy (SEM). However F1 microsphere has shown more irregular shape comparatively. The DSC studies indicated the absence of drug-polymer interaction in the microspheres. Our XRD studies have revealed that when pure drug exhibits crystalline structure with less dissolution profile, formulated microparticles can help us to obtain amorphous form of the same drug that is likely to have more dissolution property. The findings of the study suggest that the microsphere formulations were a promising carrier for quercetin delivery and can be considered as a favorable oral controlled release dosage form for hydrophobic drug quercetin. Elsevier 2015-09 2015-01-10 /pmc/articles/PMC4834692/ /pubmed/27134546 http://dx.doi.org/10.1016/j.jsps.2015.01.007 Text en © 2015 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Hazra, Moumita
Dasgupta Mandal, Dalia
Mandal, Tamal
Bhuniya, Saikat
Ghosh, Mallika
Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
title Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
title_full Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
title_fullStr Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
title_full_unstemmed Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
title_short Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
title_sort designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834692/
https://www.ncbi.nlm.nih.gov/pubmed/27134546
http://dx.doi.org/10.1016/j.jsps.2015.01.007
work_keys_str_mv AT hazramoumita designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin
AT dasguptamandaldalia designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin
AT mandaltamal designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin
AT bhuniyasaikat designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin
AT ghoshmallika designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin